Tamotsu Fukuda

Title: Innovator in Biomedicine: Tamotsu Fukuda

Introduction: Tamotsu Fukuda is a distinguished inventor based in Mobara, Japan, recognized for his significant contributions to the field of biomedicine. With a total of five patents to his name, Fukuda’s innovations focus primarily on monoclonal antibody preparations and human hybridomas, showcasing his commitment to advancing medical therapies.

Latest Patents: Among his latest patents, one notable invention is the "Freeze-dried preparation containing monoclonal antibody." This innovative freeze-dried monoclonal antibody preparation is created by incorporating gelatin or carboxylic acid (or its salt) into the monoclonal antibody solution. This technique helps to prevent denaturation of monoclonal antibodies during the freeze-drying process. The resulting preparations maintain stabilized antigen-binding activity and are intended for use in immunoauxotherapy for the prophylaxis and treatment of bacterial and viral infectious diseases.

Another significant patent is related to "Transformed cell lines producing human monoclonal antibodies specific." This invention pertains to human monoclonal antibodies that can specifically bind to the O-antigens of Pseudomonas aeruginosa. It encompasses novel parent cell lines designed for producing human hybridomas derived from human immunoglobulin synthesizing cells, which do not synthesize human immunoglobulin themselves. The invention also covers methods and pharmaceutical compositions for the prophylaxis and therapy of infections caused by Pseudomonas aeruginosa.

Career Highlights: Tamotsu Fukuda has developed a notable career as an inventor in the pharmaceutical field while working for Mitsui Toatsu Chemicals, Incorporated. His continued focus on the development of innovative solutions in medicine has earned him recognition within the biotechnology community.

Collaborations: Throughout his career, Fukuda has collaborated with esteemed coworkers such as Yasuyuki Kuroiwa and Shiro Shigeta. Their combined expertise and efforts have contributed to the advancement of groundbreaking technologies in the field of immunotherapy.

Conclusion: Tamotsu Fukuda's work exemplifies the spirit of innovation in biomedicine. His contributions, particularly in the realm of monoclonal antibodies and hybridomas, are crucial for the development of effective therapies against infectious diseases. As he continues to pioneer advancements within the industry, his inventions will no doubt play a vital role in shaping the future of immunological research and treatment.